Acetylenic sulfonamide thiol tace inhibitors
US6313123A · kind A · utility
20Cited by
8References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2000 |
| Grant date | Nov 6, 2001 |
| Priority date | — |
| Expiry date | Jan 27, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C323/49
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of formula B: ##STR1## which are useful in disease conditions mediated by TNF-.alpha., such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.